Targovax to present at the 4th Annual Next Gen Immuno-oncology Virtual Congress-US Edition
OSLO, Norway – Targovax ASA, today announces that Victor Levitsky, Chief Scientific Officer of Targovax, is invited to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition.
4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition, virtual
Date: 29 June 2021
Presenter: Victor Levitsky (CSO)
Time: 14:15 EDT / 20:15 CET
Title: Clinical efficacy and immuno-modulatory properties of oncolytic adenovirus ONCOS-102